Safety and Efficacy of Low-Dose Corticosteroids in Patients With Non-severe Coronavirus Disease 2019: A Retrospective Cohort Study

Background To date, several pharmacological agents have been employed in the treatment and management of the coronavirus disease 2019 (COVID-19). While the utility of corticosteroids in severe COVID-19 infection is now widely touted, their efficacy in thwarting the progression of non-severe disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Almas, Talal, Ehtesham, Maryam, Khan, Abdul Wali, Khedro, Tarek, Hussain, Salman, Kaneez, Mehwish, Alsufyani, Reema, Almubarak, Dana, Alahmed, Fatimah, Alaeddin, Hasan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863064/
https://www.ncbi.nlm.nih.gov/pubmed/33564538
http://dx.doi.org/10.7759/cureus.12544

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863064/
https://www.ncbi.nlm.nih.gov/pubmed/33564538
http://dx.doi.org/10.7759/cureus.12544

Ejemplares similares